|
Safety and tolerability results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab or panitumumab in patients with refractory solid tumors. |
|
|
Honoraria - AstraZeneca; BMS; Ipsen; Merck Serono; MSD |
Consulting or Advisory Role - Bayer; BMS; Janssen-Cilag; Merck Serono; MSD |
|
Patents, Royalties, Other Intellectual Property - Cyclin A1 as T-cell target |
Travel, Accommodations, Expenses - Merck Serono |
|
|
Employment - Glycotope GmbH |
|
|
Consulting or Advisory Role - Alkermes; Anaveon; Boehringer Ingelheim; Bristol-Myers Squibb; Ellipses Pharma; Janssen; MAB Discovery; NeoMed; Roche; Seagen; TFS; Thermo Fisher Scientific |
Speakers' Bureau - Lilly; MSD; Roche; Thermo Fisher Scientific |
Research Funding - AstraZeneca/MedImmune; Novartis; Roche (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Glycotope GmbH; Menarini; Merck Sharp & Dohme |
|
|
|
|
|
Konrad Friedrich Klinghammer |
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD Oncology |
|
|
Travel, Accommodations, Expenses - Astellas Pharma; Janssen |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Omar Saavedra Santa Gadea |
Travel, Accommodations, Expenses - Kyowa Kirin; MSD |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Genmab; GlaxoSmithKline; ImmunoGen; Merck Serono; PharmaMar |
Research Funding - Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar |
Expert Testimony - Clovis Oncology |
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; PharmaMar; Roche |
|
|
Employment - Glycotope GmbH |
|
|
Employment - Glycotope GmbH |
|
|
Employment - Glycotope GmbH |
Stock and Other Ownership Interests - Glycotope GmbH |
Travel, Accommodations, Expenses - Glycotope GmbH |
|
|
Consulting or Advisory Role - Abbvie; Amgen; ARIAD; Celgene; Dajichi Sankyo; Jazz Pharmaceuticals; Morphosys; Morphosys; Novartis; Pfizer |
|
Patents, Royalties, Other Intellectual Property - Patent on Immunotherapy in AML obtained together with Amgen |
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Jazz Pharmaceuticals; SERVIER |